| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Physiological Reviews, Vol. 83, No. 1, January 2003, pp. 59-115; 10.1152/physrev.00017.2002.
Copyright ©2003 by the American Physiological Society
University of Antwerp, Antwerp, Belgium
Brutsaert, Dirk L.
Cardiac Endothelial-Myocardial Signaling: Its Role in
Cardiac Growth, Contractile Performance, and Rhythmicity. Physiol. Rev. 83: 59-115, 2003.
Experimental work during the past 15 years
has demonstrated that endothelial cells in the heart play an obligatory
role in regulating and maintaining cardiac function, in particular, at the endocardium and in the myocardial capillaries where endothelial cells directly interact with adjacent cardiomyocytes. The emerging field of targeted gene manipulation has led to the contention that
cardiac endothelial-cardiomyocytal interaction is a prerequisite for normal cardiac development and growth. Some of the
molecular mechanisms and cellular signals governing this interaction,
such as neuregulin, vascular endothelial growth factor, and
angiopoietin, continue to maintain phenotype and survival of
cardiomyocytes in the adult heart. Cardiac endothelial cells, like
vascular endothelial cells, also express and release a variety of auto-
and paracrine agents, such as nitric oxide, endothelin, prostaglandin
I2, and angiotensin II, which directly influence cardiac
metabolism, growth, contractile performance, and rhythmicity of the
adult heart. The synthesis, secretion, and, most importantly, the
activities of these endothelium-derived substances in the heart are
closely linked, interrelated, and interactive. It may therefore be
simplistic to try and define their properties independently from one
another. Moreover, in relation specifically to the endocardial
endothelium, an active transendothelial physicochemical gradient for
various ions, or blood-heart barrier, has been demonstrated.
Linkage of this blood-heart barrier to the various other
endothelium-mediated signaling pathways or to the putative vascular
endothelium-derived hyperpolarizing factors remains to be
determined. At the early stages of cardiac failure, all major
cardiovascular risk factors may cause cardiac endothelial activation as
an adaptive response often followed by cardiac endothelial dysfunction.
Because of the interdependency of all endothelial signaling pathways,
activation or disturbance of any will necessarily affect the others
leading to a disturbance of their normal balance, leading to further
progression of cardiac failure.
This article has been cited by other articles:
|
|
 |
|
  J. Aitsebaomo, A. L. Portbury, J. C. Schisler, and C. Patterson Brothers and Sisters: Molecular Insights Into Arterial-Venous Heterogeneity Circ. Res., October 24, 2008; 103(9): 929 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Fraccarollo, J. D. Widder, P. Galuppo, T. Thum, D. Tsikas, M. Hoffmann, H. Ruetten, G. Ertl, and J. Bauersachs Improvement in Left Ventricular Remodeling by the Endothelial Nitric Oxide Synthase Enhancer AVE9488 After Experimental Myocardial Infarction Circulation, August 19, 2008; 118(8): 818 - 827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Mazza, A. Gattuso, C. Mannarino, B. K. Brar, S. F. Barbieri, B. Tota, and S. K. Mahata Catestatin (chromogranin A344-364) is a novel cardiosuppressive agent: inhibition of isoproterenol and endothelin signaling in the frog heart Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H113 - H122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Montano, Y. Q. Doughman, H. Deng, L. Chaplin, J. Yang, N. Wang, Q. Zhou, N. L. Ward, and M. Watanabe Mutation of the HEXIM1 Gene Results in Defects During Heart and Vascular Development Partly Through Downregulation of Vascular Endothelial Growth Factor Circ. Res., February 29, 2008; 102(4): 415 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. G. Spinale Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function Physiol Rev, October 1, 2007; 87(4): 1285 - 1342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Lemmens, K. Doggen, and G. W. De Keulenaer Role of Neuregulin-1/ErbB Signaling in Cardiovascular Physiology and Disease: Implications for Therapy of Heart Failure Circulation, August 21, 2007; 116(8): 954 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Gallo, R. Levi, R. Ramella, A. Brero, O. Boero, B. Tota, and G. Alloatti Endothelium-derived nitric oxide mediates the antiadrenergic effect of human vasostatin-1 in rat ventricular myocardium Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2906 - H2912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Davidson and M. R. Duchen Endothelial Mitochondria: Contributing to Vascular Function and Disease Circ. Res., April 27, 2007; 100(8): 1128 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Iribe, M. Helmes, and P. Kohl Force-length relations in isolated intact cardiomyocytes subjected to dynamic changes in mechanical load Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1487 - H1497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. C. Aird Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds Circ. Res., February 2, 2007; 100(2): 174 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Caspi, A. Lesman, Y. Basevitch, A. Gepstein, G. Arbel, I. H. M. Habib, L. Gepstein, and S. Levenberg Tissue Engineering of Vascularized Cardiac Muscle From Human Embryonic Stem Cells Circ. Res., February 2, 2007; 100(2): 263 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Morritt, S. K. Bortolotto, R. J. Dilley, X. Han, A. R. Kompa, D. McCombe, C. E. Wright, S. Itescu, J. A. Angus, and W. A. Morrison Cardiac Tissue Engineering in an In Vivo Vascularized Chamber Circulation, January 23, 2007; 115(3): 353 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Westerhof, C. Boer, R. R. Lamberts, and P. Sipkema Cross-talk between cardiac muscle and coronary vasculature. Physiol Rev, October 1, 2006; 86(4): 1263 - 1308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-H. Zimmermann, M. Didie, S. Doker, I. Melnychenko, H. Naito, C. Rogge, M. Tiburcy, and T. Eschenhagen Heart muscle engineering: An update on cardiac muscle replacement therapy Cardiovasc Res, August 1, 2006; 71(3): 419 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lemmens, V. F. M. Segers, M. Demolder, and G. W. De Keulenaer Role of Neuregulin-1/ErbB2 Signaling in Endothelium-Cardiomyocyte Cross-talk J. Biol. Chem., July 14, 2006; 281(28): 19469 - 19477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Naito, I. Melnychenko, M. Didie, K. Schneiderbanger, P. Schubert, S. Rosenkranz, T. Eschenhagen, and W.-H. Zimmermann Optimizing Engineered Heart Tissue for Therapeutic Applications as Surrogate Heart Muscle Circulation, July 4, 2006; 114(1_suppl): I-72 - I-78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Rocic, B. Rezk, and P. A. Lucchesi PPAR-{gamma} agonists decrease hyperhomcysteinemia and cardiac dysfunction: new hope for ailing diabetic hearts? Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H26 - H28. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bras-Silva, A. P. Fontes-Sousa, C. Moura, J. C. Areias, and A. F. Leite-Moreira Impaired Response to ETB Receptor Stimulation in Heart Failure: Functional Evidence of Endocardial Endothelial Dysfunction? Experimental Biology and Medicine, June 1, 2006; 231(6): 893 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Izumiya, I. Shiojima, K. Sato, D. B. Sawyer, W. S. Colucci, and K. Walsh Vascular Endothelial Growth Factor Blockade Promotes the Transition From Compensatory Cardiac Hypertrophy to Failure in Response to Pressure Overload Hypertension, May 1, 2006; 47(5): 887 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. F. M. Segers, I. Van Riet, L. J. Andries, K. Lemmens, M. J. Demolder, A. J. M. L. De Becker, M. M. Kockx, and G. W. De Keulenaer Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1370 - H1377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Eschenhagen and W. H. Zimmermann Engineering Myocardial Tissue Circ. Res., December 9, 2005; 97(12): 1220 - 1231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Su, Q. Zhang, J. Moalem, J. Tse, P. M. Scholz, and H. R. Weiss Functional effects of C-type natriuretic peptide and nitric oxide are attenuated in hypertrophic myocytes from pressure-overloaded mouse hearts Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1367 - H1373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Westerhof Nitric oxide and efficiency of the right heart Cardiovasc Res, December 1, 2004; 64(3): 379 - 380. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Li, X. Hu, P. Selvakumar, R. R. Russell III, S. W. Cushman, G. D. Holman, and L. H. Young Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E834 - E841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pellegrino, C. A. Palmerini, and B. Tota No hemoglobin but NO: the icefish (Chionodraco hamatus) heart as a paradigm J. Exp. Biol., October 15, 2004; 207(22): 3855 - 3864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hendrickx, K. Doggen, E. O. Weinberg, P. Van Tongelen, P. Fransen, and G. W. De Keulenaer Molecular diversity of cardiac endothelial cells in vitro and in vivo Physiol Genomics, October 4, 2004; 19(2): 198 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Leite-Moreira and C. Bras-Silva Inotropic effects of ETB receptor stimulation and their modulation by endocardial endothelium, NO, and prostaglandins Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1194 - H1199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Fransen, R. R Lamberts, J. Hendrickx, and G. W De Keulenaer Endocardial endothelium modulates subendocardial pHi of rabbit papillary muscles: role of transendothelial HCO3- transport Cardiovasc Res, September 1, 2004; 63(4): 700 - 708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Narmoneva, R. Vukmirovic, M. E. Davis, R. D. Kamm, and R. T. Lee Endothelial Cells Promote Cardiac Myocyte Survival and Spatial Reorganization: Implications for Cardiac Regeneration Circulation, August 24, 2004; 110(8): 962 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Adler, H. Huang, Z. Wang, J. Conetta, E. Levee, X. Zhang, and T. H. Hintze Endocardial endothelium in the avascular frog heart: role for diffusion of NO in control of cardiac O2 consumption Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H14 - H21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Boczkowski Lung Infection and the Diaphragm: Placing Basic Research in Clinical Perspective Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 662 - 663. [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Hall, R. Hurtado, K. W. Hewett, M. Shulimovich, C. P. Poma, M. Reckova, C. Justus, D. J. Pennisi, K. Tobita, D. Sedmera, et al. Hemodynamic-dependent patterning of endothelin converting enzyme 1 expression and differentiation of impulse-conducting Purkinje fibers in the embryonic heart Development, February 1, 2004; 131(3): 581 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Lemmens, P. Fransen, S. U. Sys, D. L. Brutsaert, and G. W. De Keulenaer Neuregulin-1 Induces a Negative Inotropic Effect in Cardiac Muscle: Role of Nitric Oxide Synthase Circulation, January 27, 2004; 109(3): 324 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.B. Massion, O. Feron, C. Dessy, and J.-L. Balligand Nitric Oxide and Cardiac Function: Ten Years After, and Continuing Circ. Res., September 5, 2003; 93(5): 388 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Reckova, C. Rosengarten, A. deAlmeida, C. P. Stanley, A. Wessels, R. G. Gourdie, R. P. Thompson, and D. Sedmera Hemodynamics Is a Key Epigenetic Factor in Development of the Cardiac Conduction System Circ. Res., July 11, 2003; 93(1): 77 - 85. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
